Translated industry
We helped sponsors, sites, and health systems explain themselves in necessarily plain language — no jargon, no hedging, no talking past people.

Standing in the gap between industry and the patient community — translating clinical research into plain language people can trust.
Look out for what’s nextPatient advocacy. Patient engagement. Honest, meaningful communication between the people who develop medicine and the people it is meant to serve.
Clinical Ambassador was built for communities that have been underrepresented, underserved, and justifiably hesitant — where distrust is not a misunderstanding to be corrected but a history to be respected. Our work begins there, with plain language, straight answers, and the patience that earned trust requires.
Clinical Ambassador created this category. Others have followed.
Why the name
An ambassador is sent to represent one world to another with care — carrying intent, keeping their word, and answering for what they say. That is the job here: representing clinical research to communities, and communities back to industry, with nothing lost in translation.
We helped sponsors, sites, and health systems explain themselves in necessarily plain language — no jargon, no hedging, no talking past people.
We delivered the case for participation from the patient's point of view, grounded in anecdotal testimony from people who had actually been there.
Lived experience and the evidence together. Neither one alone was enough to move a hesitant community toward an informed yes — or an informed no.
Proven strategies
Enrollment targets met and exceeded. Timelines held. Communities that had been written off as unreachable, reached. But the number the industry never thought to track is the one we built our practice around.
Exceeded
Recruitment and retention metrics across sponsor programs
Proven
Strategies refined in the field, not in a deck
Trust
The metric we created — and the one that compounds
We made the trustworthiness of industry sponsors, clinical studies, their representatives at every title and level, and the clinical research enterprise writ large into something a community can actually assess — and something a sponsor can actually earn.
Setting a standard
Sponsors called us when enrollment stalled. Imagine your own numbers if patients and patient engagement were the priority from day one.
This is a sector organized around profit, and rarely around sharing it with the people on the ground who make the science possible. We reject that as the whole scorecard.
We believe in the work, in the results we have generated, and in the value of the relationships behind them. Community and patient trust — and the ability to connect the dots between a hesitant person and a life-changing medical advance — matters more.
Allison Kalloo, MPH is the Yale-educated founder of Clinical Ambassador and a longtime voice in patient advocacy and clinical trial engagement. She built her practice on a simple premise: patients deserve to be spoken with, not marketed at — and the communities most often left out of research are the ones whose participation matters most.
Connect with Allison on LinkedInSomething new is coming to this address — a patient engagement solution that leverages technology without pretending technology is the whole answer.
Because the thing that actually moves people is still the thing it has always been: direct human contact. Real conversation. A person who shows up, listens, and tells the truth. We’re doubling down on that, and building the tools to make it scale.
Be first to hear what’s next from Clinical Ambassador. No noise — just the announcement when it’s ready.